Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconREGNRegeneron Pharmaceuticals$65.88bn14.98n/a
us flag iconSGENSeagen$43.15bnn/an/a
us flag iconIQVIqvia Holdings$26.50bn19.3n/a
us flag iconBNTXBioNTech SE$24.48bnn/an/a
us flag iconSMMTSummit Therapeutics$17.31bnn/an/a
us flag iconINSMInsmed$12.67bnn/an/a
us flag iconKRTXKaruna Therapeutics$12.58bnn/an/a
us flag iconICLRIcon$11.71bn13.34n/a
us flag iconMRNAModerna$10.52bnn/an/a
us flag iconEXELExelixis$10.32bn18.9n/a
us flag iconASNDAscendis Pharma A/S$9.96bnn/an/a
us flag iconRXDXPrometheus Biosciences$9.56bnn/an/a
us flag iconTEMTempus AI$9.15bnn/an/a
us flag iconQGENQiagen NV$9.09bn25.7n/a
us flag iconIMGNImmunoGen$8.72bnn/an/a
us flag iconMEDPMedpace Holdings$8.58bn22.78n/a
us flag iconEXASExact Sciences$8.44bnn/an/a
us flag iconCERECerevel Therapeutics Holdings$8.19bnn/an/a
us flag iconTECHBIO-TECHNE$7.94bn38.770.64%
us flag iconMDGLMadrigal Pharmaceuticals$7.22bnn/an/a